Use of psychotropics in Sydney nursing homes: Associations with depression, psychosis, and behavioral disturbances

International Psychogeriatrics

Volumn 13, Issue 1, 2001, Pages 107-120

  Draper, Brian ^a,b   Brodaty, Henry ^a,b   Low, Lee Fay ^b   Saab, Dania ^b   Lie, David ^b   Richards, Vicki ^b   Paton, Helen ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; CHLORPROMAZINE; FLUOXETINE; HYPNOTIC SEDATIVE AGENT; LITHIUM; MIANSERIN; MOCLOBEMIDE; NEUROLEPTIC AGENT; NORTRIPTYLINE; PAROXETINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROIC ACID; VENLAFAXINE;

ADULT; AFFECTIVE NEUROSIS; AGED; AGGRESSIVENESS; ARTICLE; AUSTRALIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELUSION; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NURSING HOME; PRESCRIPTION; PREVALENCE; PSYCHOSIS; RATING SCALE;

AGED; AGED, 80 AND OVER; DEMENTIA; DEPRESSION; DRUG UTILIZATION; FEMALE; HOMES FOR THE AGED; HUMANS; INPATIENTS; MALE; MENTAL DISORDERS; NEW SOUTH WALES; NURSING HOMES; PSYCHOTIC DISORDERS; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES;

EID: 0035012352     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610201007505     Document Type: Article

References (49)

1. Effects of group interventions on cognition and depression in nursing home residents
2. A brief sensitive screening instrument for depression in late life
3. Practice guidelines for major depressive disorder in adults
4. Pharmacological treatment of agitation in a nursing home
5. Environmental 'white noise': An intervention for verbally agitated nursing home residents
6. Psychotropic drug prescriptions for nursing home residents
7. Neuroleptic use and behavioral disturbance in nursing homes: A 1-year study
8. A controlled study of disruptive vocalizations among geriatric residents in nursing homes
9. Informed consent for research in a nursing home: Processes and issues
10. Psychotropic drug utilization in long-term-care facilities for the elderly in Ontario, Canada
11. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease
12. Case-controlled study of nursing home residents referred for treatment of vocally disruptive behavior
13. Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances
14. Evaluation of a mental test score for assessment of mental impairment in the elderly
15. Evaluation of a clinical intervention for wanderers on a geriatric nursing unit
16. Treating geriatric depression
17. Comparison of risperidone and placebo for psychosis and behavioural disturbances associated with dementia: A randomized, double-blind trial
18. Pharmacologic treatment of major depression for elderly patients in residential care settings
19. Psychiatric morbidity in Hobart's dependent aged
20. Use of psychotropic drugs in a group of nursing home patients with dementia: Many users, long term use but low dosages
21. A ten-year review of the effect of OBRA-87 on psychotropic prescription practices in an academic nursing home
22. Newer psychotropic medication use in nursing home residents
23. A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease
24. Survey of neuroleptic prescribing in residents of nursing homes in Glasgow
25. Predictors of antipsychotic withdrawal or dose reduction in a randomized controlled trial of provider education
26. Medication use and costs for nursing home patients: Relationship to level of care needed
27. Medication in nursing homes. A study of psychoactive drug use
28. The need for a more rational approach to drug prescribing for elderly people in nursing homes
29. Consumption of psychotropic drugs in nursing home residents: A prospective study in patients permanently admitted to a nursing home
30. Practical guidelines for the treatment of behavioural complications of dementia
31. The prevalence of depression among Australian nursing home residents: Results using draft ICD-10 and DSM-III-R criteria
32. Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment
33. Project to optimise the quality of drug use in the elderly in long term facilities in Australia
34. Care needs of people with dementia and challenging behaviours living in residential facilities
35. A randomized trial of dementia care in nursing homes
36. Serotonin reuptake inhibitors and the adequacy of antidepressant treatment
37. Medication use by elderly persons in Sydney
38. A follow-up survey of psychotropic drug use in Sydney nursing homes
39. Use of antidepressants, and the prevalence of depression and cognitive impairment in Sydney nursing homes
40. Psychotropic drug use in Sydney nursing homes
41. Nursing home resources and tranquilizer use among the institutionalised elderly
42. Behavioral treatment of depression in dementia patients: A controlled clinical trial
43. Use of SSRIs in "very old" depressed nursing home residents
44. Use of psychopharmaceuticals in municipal nursing homes. A nationwide survey
45. The Even Briefer Assessment Scale for Depression (EBAS DEP): Its suitability for the elderly in geriatric care in English- and German-speaking countries
46. The effect of natural environments upon agitation and aggression in late stage dementia patients
47. Out of the darkness: Group cognitive therapy for the depressed elderly